ALLMedicine™ Postpartum Hemorrhage Center

May 21st, 2022 - To assess incidence and risk factors for postpartum hemorrhage (PPH) and identify women at high risk of recurrence in the subsequent pregnancy. This register-based study includes data on women from the Capital Region of Denmark with two consecutiv...

May 20th, 2022 - Diffuse Uterine Arteriovenous Malformations as an Unusual Cause of Secondary Postpartum Hemorrhage.|2022|Campos CI,Kujundzic W,Vergara-Galliadi LM,Ávila F,Nieto-Calvache AJ,|

May 18th, 2022 - To clarify the perinatal outcome of retained products of conception (RPOC) after 22 weeks or more. The retrospective cohort study reviewed medical records of patients with RPOC without placenta previa at 186 Japanese perinatal centers. Of the 323 ...

May 17th, 2022 - Placenta accreta, which was a rare diagnosis before, is now one of the most important causes of postpartum hemorrhage and hysterectomy. Trigger receptor expressed on myeloid cells (TREM), interacts with Toll-like receptors (TLRs) that play an impo...

May 16th, 2022 - Higher rates of postpartum hemorrhage (PPH) have been reported for women with von Willebrand disease (VWD). Comprehensive multidisciplinary care reduces these rates; thus PPH may not be secondary to VWD. We conducted a retrospective review for the...

Nov 7th, 2020 - Postpartum hemorrhage (PPH) can be categorized as primary or early if occurring in the first 24 hours after delivery, whereas late or delayed PPH occurs between 24 hours and 6 weeks. Most of the causes of PPH can be diagnosed clinically, but imagi...

Nov 26th, 2019 - Postpartum hemorrhage causes approximately 11% of maternal deaths in the United States and is the leading cause of death that occurs on the day of birth. Importantly, 54-93% of maternal deaths due to obstetric hemorrhage may be preventable. Studie...

Nov 26th, 2019 - Postpartum hemorrhage causes approximately 11% of maternal deaths in the United States and is the leading cause of death that occurs on the day of birth. Importantly, 54-93% of maternal deaths due to obstetric hemorrhage may be preventable. Studie...

Sep 25th, 2017 - Maternal hemorrhage, defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process, remains the leading cause of maternal mortality wor...

Jan 17th, 2016 - Postpartum haemorrhage (PPH) is defined as blood loss ≥500mL after delivery and severe PPH as blood loss ≥1000mL, regardless of the route of delivery (professional consensus). The preventive administration of uterotonic agents just after delivery ...

May 17th, 2022 - Placenta accreta, which was a rare diagnosis before, is now one of the most important causes of postpartum hemorrhage and hysterectomy. Trigger receptor expressed on myeloid cells (TREM), interacts with Toll-like receptors (TLRs) that play an impo...

Apr 28th, 2022 - Rationale and background: Given the limitations of animal reproductive studies, pre-approval clinical trials in human populations, and post-marketing spontaneous adverse event reports to produce evidence on the safety of medical products and vacci...

Apr 22nd, 2022 - The purpose of this implementation research study is to generate evidence that informs the successful uptake and adoption of the Ellavi UBT within Kenyan MOH PPH management programs for both public and private sector programs. The investigators ai...

Apr 22nd, 2022 - Oxytocin is the most commonly used uterotonic agent worldwide to achieve adequate uterine tone and prevent postpartum hemorrhage. Over the past decade, the trend has been towards lowering the dose to reduce oxytocin-related adverse effects includi...

Apr 20th, 2022 - This randomized control trial will be conducted at Tanta University hospital, Egypt, from 2022 to 2024. Tanta University Hospital is considered the main tertiary hospital at the center of Nile Delta . Cases, suspected to have PAS, are recruited fr...

Apr 26th, 2022 - Multifetal pregnancy reduction (MPR) was developed in the 1980s in the wake of significant increases in the incidence of triplets and other higher-order multiples emanating from assisted reproductive technologies (ART). It was offered to reduce fe...

Feb 24th, 2022 - Use of neuraxial analgesia for vaginal delivery is associated with a 14% decreased risk for severe maternal morbidity, in part from a reduction in postpartum hemorrhage, new research shows. The findings indicate that increasing the use of epidural...

Feb 19th, 2022 - Members of the LGBTQ community who give birth appear to have a greater risk of hypertensive disorders of pregnancy and postpartum hemorrhage, according to new research presented at the annual meeting sponsored by the Society for Maternal-Fetal Med...

Feb 8th, 2022 - Members of the LGBTQ community who give birth appear to have a greater risk of hypertensive disorders of pregnancy and postpartum hemorrhage, according to new research presented at the annual meeting sponsored by the Society for Maternal-Fetal Med.

Feb 4th, 2022 - Methylergonovine is often used to control severe bleeding immediately after cesarean deliveries. But a new study suggests that the ergot alkaloid agent could benefit these women if administered before delivery, researchers from the University of I...